London: Owing to the rising geriatric population and subsequently increased burden of cardiovascular diseases, Japan is leading the Asia-Pacific’s clot management devices market and is expected to retain its position through 2025, according to GlobalData.
Ayshi Ganguly, Medical Devices, Analyst, GlobalData, commented, “With Japan leading the world’s ageing population, there is always scope for innovation in the field of medical equipment, and this provides an opportunity for foreign companies to invest in the country.”
GlobalData’s report, ‘Clot Management Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030,’ reveals that Japan’s clot management market is currently led by foreign companies such as Boston Scientific Corp, Teleflex Inc and Penumbra Inc. These companies collectively accounted for around 70 per cent of the market in 2021.
Penumbra Inc and Asahi Intecc Co Ltd, a Japanese medical device company, have recently announced a collaboration to bring Penumbra’s Indigo aspiration system to the Japanese market once regulatory approval is obtained. Through this collaboration, Penumbra Inc will have an opportunity to utilise Asahi’s leadership and expertise in the Japanese market.
Ganguly concluded, “Through collaborations and innovations, Japan aims to become the home for many leading medical device firms and provide its people with the best and latest available treatment options. This will also allow foreign companies to expand their network and thereby increase their market share.”